Angiotensin-Converting Enzyme Inhibition Increases Human Vascular Tissue-Type Plasminogen Activator Release Through Endogenous Bradykinin

Keywords

Enalaprilat, Bradykinin, Endocrinology, Internal medicine, Medicine

References

• Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction.Robert A. Wright, Andrew D. Flapan, K G Alberti — 1994
• NG-Monomethyl-l-ARG Reduces the Forearm Vasodilator Response to Acetylcholine but Not to Methacholine in HumansGerard A. Rongen, Paul Smits, Theo Thien — 1993
• Comparative Effects of Estrogen and Angiotensin-Converting Enzyme Inhibition on Plasminogen Activator Inhibitor-1 in Healthy Postmenopausal WomenNancy J. Brown, Amira Abbas, Daniel W. Byrne — 2002
• An Endothelial Storage Granule for Tissue-Type Plasminogen ActivatorJ.J. Emeis, Y van den Eijnden-Schrauwen, C.M. van den Hoogen — 1997
• Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators.Douglas E. Vaughan, Jean‐Lucien Rouleau, Paul M. Ridker — 1997
• Ramipril prevents major cardiovascular events in high-risk women: results of the HOPE trialEva Lonn, Rosa Roccaforte, Qilong Yi — 2002
• The effects of the angiotensin-converting enzyme inhibitor imidapril on plasma plasminogen activator inhibitor activity in patients with acute myocardial infarction.Shuichi Oshima, Hisao Ogawa, Yuji Mizuno — 1997
• Comparison of cholinergic vasodilator responses to acetylcholine and methacholine in the human forearm.Tobias A. Bruning, Peter C. Chang, Michiel J. B. Kemme — 1996
• Role of bradykinin in the vasodilator effects of losartan and enalapril in patients with heart failure.Andrew Davie, Henry J. Dargie, John J.V. McMurray — 1999
• Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex: relationship to elevated TPA antigen in patients with high PAI-1 activity levels.Wayne L. Chandler, Marie‐Christine Alessi, M.F. Aillaud — 1997
• Human coronary arteriolar dilation to bradykinin depends on membrane hyperpolarization: contribution of nitric oxide and Ca2+-activated K+ channels.Hiroto Miura, Yanping Liu, David D. Gutterman — 1999
• Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors.William B. Campbell, Debebe Gebremedhin, Phillip F. Pratt — 1996
• 17Beta-estradiol acutely improves endothelium-dependent relaxation to bradykinin in isolated human coronary arteries.Matthias Barton, Jochen Cremer, Andreas Mügge — 1998
• Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway.Julio A. Panza, Carlos Garcia, Crescence M. Kilcoyne — 1995
• Captopril improves impaired endothelium-dependent vasodilation in hypertensive patients.Y Hirooka, Takahiro Imaizumi, Hiroaki Masaki — 1992
• Cough and Angioneurotic Edema Associated with Angiotensin-Converting Enzyme Inhibitor TherapyZafar H. Israili, Wayne Hall — 1992
• Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study.T MEADE — 1993
• Endothelium-Dependent Vasodilation is Augmented by Angiotensin Converting Enzyme Inhibitors in Healthy VolunteersMotoyuki Nakamura, Tsutomu Funakoshi, Hiroaki Yoshida — 1992
• Acetylcholine-Mediated Vasodilatation and Tissue-type Plasminogen Activator Release in Normal and Hypertensive MenGiulia Dell’Omo, Laura Ferrini, Marco Morale — 1999
• Inositol trisphosphate/Ca2+ as messengers of bradykinin B2 and muscarinic acetylcholine m1-m4 receptors in neuroblastoma-derived hybrid cells.Mami Noda, Nobuto Ishizaka, Shigeru Yokoyama — 1996

Cited by

• Inhibition of RAAS—When is it too much?Yozo Hida, Xiaoye Sherry Li, David H. Bailey — 2004
• INFLAMACIÓN Y TROMBOSIS: DEL LABORATORIO A LA CLÍNICAJosé A. Páramo, A. Estellés — 2003
• Impairment of Endothelial Thromboprotective Function by Haemodynamic and Inflammatory Stress Implications for hypertensive diseaseErik Ulfhammer — 2007
• Regulation of Kinin Receptor Expression in Heart Failure with a Focus on Vascular EndotheliumInka Liesmaa — 2010
• Carvedilol‐Lisinopril Combination Therapy and Endothelial Function in Obese Individuals With HypertensionAaron S. Kelly, J. Michael González-Campoy, Kyle Rudser — 2012
• Plasma Plasminogen Activator Inhibitor 1 (PAI-1) and p-Selectin Levels in Urgent Hypertension: Effect of Single Dose Captopril and Nifedipin on Fibrinolytic ActivityÖzlem Tiryaki, Hakan Büyükhatipoğlu, Celalettin Usalan — 2010
• Angiotensin-converting enzyme inhibition alters the inflammatory and fibrinolytic response to cardiopulmonary bypass in children*Gregory A. Fleming, Frederic T. Billings, Tom Klein — 2011
• The kallikrein-kinin system: current and future pharmacological targets.Marie Eve Moreau, Nancy Garbacki, Giuseppe A. Molinaro — 2005
• Met-Lys-bradykinin-Ser-Ser, a peptide produced by the neutrophil from kininogen, is metabolically activated by angiotensin converting enzyme in vascular tissue.Lajos Gera, Caroline Roy, Marie‐Thérèse Bawolak — 2011
• Impact of kinins in the treatment of cardiovascular diseases.D. Regoli, Gérard E. Plante, Fernand Gobeil — 2012
• The prothrombotic paradox of hypertension: role of the renin-angiotensin and kallikrein-kinin systems.Arne W. J. H. Dielis, Machiel Smid, Henri M.H. Spronk — 2005
• Vascular injury in systemic sclerosis: Angiotensin-converting enzyme insertion/deletion polymorphismCinzia Fatini, Serena Guiducci, Rosanna Abbate — 2004
• ACE inhibition reduces activity of the plasminogen/plasmin and MMP systems in the brain of spontaneous hypertensive stroke-prone rats.Martin Liebetrau, Dorothe Burggraf, Nathalie Wunderlich — 2005
• Kinins and cardiovascular diseases.Jin Bo Su — 2006
• An in vitro reconstitution system to address the mechanism of the vascular expression of the bradykinin B₁ receptor in response to angiotensin converting enzyme inhibition.Caroline Roy, Emilie Marceau, Lajos Gera — 2012
• Microvascular tissue plasminogen activator is reduced in diabetic neuropathyCharlene E. Hafer‐Macko, Frederick M. Ivey, John D. Sorkin — 2007
• Effects of Losartan and Delapril on the Fibrinolytic System in Patients with Mild to Moderate HypertensionSalvatore Paterna, Vincenzo Di Garbo, Gino Avellone — 2003
• Low HDL Cholesterol, Smoking and IL-13 R130Q Polymorphism are Associated with Myocardial Infarction in Greek Cypriot Males. A Pilot StudyStavroulla Xenophontos, Marilena Hadjivassiliou, Alex Karagrigoriou — 2008
• NO-Dependent Endothelial Dysfunction in Type II Diabetes Is Aggravated by Dyslipidemia and Hypertension, but Can Be Restored by Angiotensin-Converting Enzyme Inhibition and Weight LossInes Nevelsteen, An Van den Bergh, Gerry Van der Mieren — 2013
• Impaired fibrinolysis in retinal vein occlusion: a role for genetic determinants of PAI-1 levelsRossella Marcucci, Cinzia Fatini, Francesca Gensini — 2004

Related papers

• Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE.Claudio Ceconi, Gloria Francolini, Adriana Olivares — 2007
• Comparison of a Vasopeptidase Inhibitor with Neutral Endopeptidase and Angiotensin-Converting Enzyme Inhibitors on Bradykinin Metabolism in the Rat Coronary BedMarie–Josée Dumoulin, Albert Adam, Jean‐Lucien Rouleau — 2001
• Angiotensin‐converting enzyme inhibition improves venous endothelial dysfunction in chronic smokersSylvie Chalon, H MORENOJR, Brenda J. Hoffman — 1999
• Increased bradykinin levels accompany the hemodynamic response to acute inhibition of angiotensin-converting enzyme in dogs with heart failure.Jin Bo Su, Fabrice Barbe, Bertrand Crozatier — 1999
• Inhibition of angiotensin‐converting enzyme in human hand veinsSylvie Chalon, Gabriella Bedarida, H MORENOJR — 1999
• Addition of Angiotensin II Receptor Antagonist to an ACE Inhibitor in Heart Failure Improves Cardiovascular Function by a Bradykinin-Mediated MechanismTakafumi Koji, Katsuya Onishi, Kaoru Dohi — 2003
• A comparison of the effects of angiotensin-converting enzyme inhibitors with bradykinin, angiotensin II and their specific antagonists on concanavalin A-induced proliferation of mouse T-lymphocytes.J.H.K. Yeung — 1994
• Role of angiotensin II and bradykinin on aortic collagen following converting enzyme inhibition in spontaneously hypertensive rats.Athanase Bénétos, Bernard Lévy, Patrick Lacolley — 1997
• Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I.Anthony J. Greco, Ryan G. Master, Alex Fokin — 2006
• Effects of angiotensin-converting enzyme inhibition on arterial, venous and capillary functions in cat skeletal muscle in vivo.Ulf Ekelund — 1996